MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jcyt.2024.07.015

Медицинская библиотека · Cytotherapy · 2024

Late-onset relapsing neurotoxicity after Brexucabtagene autoleucel associated with high chimeric antigen receptor T cells in cerebrospinal fluid.

De Philippis Chiara, Giacomel Arianna, Pensato Umberto, Pinton Chiara, Taurino Daniela, Mannina Daniele, Mariotti Jacopo, Sarina Barbara, Marcheselli Simona, Timofeeva Inna, Capizzuto Rossana, Santoro Armando, Bramanti Stefania

Клинический случайСтатьяПеревод в очереди

Аннотация

BACKGROUND AIMS: Mounting evidence suggests that persistent cell expansion is the main driver for both efficacy and toxicity of chimeric antigen receptor (CAR) T-cell therapy. Hereby, we describe a case of delayed recurrent neurotoxicity associated with late CAR T-cells re-expansion.

CASE DESCRIPTION: A 44-year-old man suffering from mantle cell lymphoma received brexu-cel. After infusion, he developed grade 2 cytokine release syndrome. On day +11, grade 3 neurotoxicity was reported and high-dose methylprednisolone was started with a complete resolution of neurological manifestations. On day +30, he experienced a late-onset CAR T-cell toxicity associated with CAR T-cell re-expansion. The patient was treated with tocilizumab and dexamethasone, with resolution of symptoms. On day +58, he was readmitted for new onset of neurotoxicity. Notably, a new CAR T-cell expansion was observed, with an unexpectedly elevated cerebrospinal fluid/blood ratio. The patient was promptly treated with dexamethasone and then escalated to high-dose methylprednisolone and anakinra, with resolution of his neurologic condition noted.

CONCLUSIONS

CAR T-cell-related neurotoxicity usually has an early monophasic course. To our knowledge, this is the first case of late-onset, recurrent neurotoxicity. Moreover, an elevated level of cerebrospinal fluid CAR T cells was observed, which may suggest that the delayed neurotoxicity was primarily caused by the brain infiltration of CAR T cells rather than driven by cytokine-mediated neuroinflammation.

Для цитирования: De Philippis Chiara, Giacomel Arianna, Pensato Umberto, Pinton Chiara, Taurino Daniela, Mannina Daniele, Mariotti Jacopo, Sarina Barbara, Marcheselli Simona, Timofeeva Inna, Capizzuto Rossana, Santoro Armando, Bramanti Stefania. Late-onset relapsing neurotoxicity after Brexucabtagene autoleucel associated with high chimeric antigen receptor T cells in cerebrospinal fluid.. Cytotherapy. 2024. DOI: 10.1016/j.jcyt.2024.07.015.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.